TIS 0.00% 0.0¢ tissue therapies limited

help(2), page-10

  1. 44 Posts.
    TDA

    In this extremely competitive world of pharmaceuticals, I don’t believe for one moment that if we played by the correct rules that the expected results would be achieved in good time unhindered by the existing rich and powerful pharma’s. That would be an ideal world. What has happened to TIS is now academic. I am merely pointing out the real possibility of having more unexpected, illogical excuses for delaying TIS in the next stage of approval. If all else fails, file could be “misplaced” or a vital chapter “missing” and no one bothers to inform TIS for months ……etc…

    In order to cater for all eventualities, as I suggested, there should be Plans A, B, C, D, E ….I am in favour of the US trial but let us not push aside other avenues that cost VERY little time, money and efforts. Some options can proceed simultaneously without too much exertion.

    In this days and age, mass awareness is everything. If done with the right credentials and correctly, it can happen overnight. I would not under estimate the value of an Australian approval. With or even without an Australian approval, the value of bringing worldwide awareness to this product is INVALUABLE. If the whole world is made aware of this product, what is there to stop the other medical tourism countries from ordering a ton of it next quarter? TIS will be a Monopoly and be able to negotiate from the driver seat. But charity should start at home – fight for the 4000 Australian would-be amputees first! If you do the right thing first, money will come to you in unexpected ways in no time (shhhh …..it’s a Secret).

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.